Precision Neuroscience
About
What does Precision Neuroscience do?
Precision Neuroscience is a startup focused on creating a minimally invasive brain-computer interface (BCI) called the 'Lifeblood' system. This system aims to enable high-bandwidth neural data acquisition and stimulation, with the ultimate goal of treating neurological conditions and restoring lost function.
What is Precision Neuroscience's valuation?
StartupHub estimates Precision Neuroscience's effective valuation at $195.8M (range $125.0M to $300.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Precision Neuroscience raised?
Precision Neuroscience has raised a total of $50M in funding. The most recent round on record is Series B.
Where is Precision Neuroscience headquartered?
Precision Neuroscience is headquartered in San Francisco, United States.
When was Precision Neuroscience founded?
Precision Neuroscience was founded in 2021.
What industry does Precision Neuroscience operate in?
Precision Neuroscience operates in Neurotech & HCI, Brain-Computer Interface, Non-Invasive BCI, Neural Read/Write, Medical Devices, HealthTech.
What is Precision Neuroscience's current status?
Precision Neuroscience's current operating status is: Inactive.
No comments yet. Be the first to share your take.